nodes	percent_of_prediction	percent_of_DWPC	metapath
Norepinephrine—Salbutamol—chronic obstructive pulmonary disease	0.378	1	CrCtD
Norepinephrine—ADRB2—chronic obstructive pulmonary disease	0.0858	0.547	CbGaD
Norepinephrine—CYP1A2—chronic obstructive pulmonary disease	0.0709	0.453	CbGaD
Norepinephrine—Phenylephrine—Salbutamol—chronic obstructive pulmonary disease	0.0361	0.144	CrCrCtD
Norepinephrine—Arbutamine—Formoterol—chronic obstructive pulmonary disease	0.0355	0.142	CrCrCtD
Norepinephrine—Arbutamine—Arformoterol—chronic obstructive pulmonary disease	0.0355	0.142	CrCrCtD
Norepinephrine—Isoetarine—Salbutamol—chronic obstructive pulmonary disease	0.0307	0.123	CrCrCtD
Norepinephrine—ADRB2—Salbutamol—chronic obstructive pulmonary disease	0.0304	0.17	CbGbCtD
Norepinephrine—ADRB1—Salbutamol—chronic obstructive pulmonary disease	0.0299	0.167	CbGbCtD
Norepinephrine—Levonordefrin—Salbutamol—chronic obstructive pulmonary disease	0.0269	0.107	CrCrCtD
Norepinephrine—Isoprenaline—Formoterol—chronic obstructive pulmonary disease	0.0233	0.0929	CrCrCtD
Norepinephrine—Isoprenaline—Arformoterol—chronic obstructive pulmonary disease	0.0233	0.0929	CrCrCtD
Norepinephrine—ADRB2—Arformoterol—chronic obstructive pulmonary disease	0.023	0.129	CbGbCtD
Norepinephrine—ADRB2—Formoterol—chronic obstructive pulmonary disease	0.023	0.129	CbGbCtD
Norepinephrine—ADRB1—Formoterol—chronic obstructive pulmonary disease	0.0227	0.127	CbGbCtD
Norepinephrine—ADRB1—Arformoterol—chronic obstructive pulmonary disease	0.0227	0.127	CbGbCtD
Norepinephrine—Epinephrine—Salbutamol—chronic obstructive pulmonary disease	0.0217	0.0866	CrCrCtD
Norepinephrine—SLC22A5—Tiotropium—chronic obstructive pulmonary disease	0.0215	0.12	CbGbCtD
Norepinephrine—Isoprenaline—Salbutamol—chronic obstructive pulmonary disease	0.0177	0.0704	CrCrCtD
Norepinephrine—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.00596	0.0333	CbGbCtD
Norepinephrine—Lactic acidosis—Salbutamol—chronic obstructive pulmonary disease	0.0015	0.141	CcSEcCtD
Norepinephrine—Extravasation—Aminophylline—chronic obstructive pulmonary disease	0.000584	0.0547	CcSEcCtD
Norepinephrine—Pallor—Salbutamol—chronic obstructive pulmonary disease	0.000442	0.0414	CcSEcCtD
Norepinephrine—Aggression—Montelukast—chronic obstructive pulmonary disease	0.000433	0.0405	CcSEcCtD
Norepinephrine—Aggression—Salbutamol—chronic obstructive pulmonary disease	0.000417	0.0391	CcSEcCtD
Norepinephrine—Blood pressure increased—Arformoterol—chronic obstructive pulmonary disease	0.000388	0.0363	CcSEcCtD
Norepinephrine—Blood pressure increased—Formoterol—chronic obstructive pulmonary disease	0.000388	0.0363	CcSEcCtD
Norepinephrine—Blood pressure increased—Salbutamol—chronic obstructive pulmonary disease	0.000366	0.0343	CcSEcCtD
Norepinephrine—Anxiety—Roflumilast—chronic obstructive pulmonary disease	0.000284	0.0266	CcSEcCtD
Norepinephrine—Isoetarine—ADRB2—chronic obstructive pulmonary disease	0.000248	0.165	CrCbGaD
Norepinephrine—Arrhythmia—Aminophylline—chronic obstructive pulmonary disease	0.000229	0.0214	CcSEcCtD
Norepinephrine—Arrhythmia—Tiotropium—chronic obstructive pulmonary disease	0.000216	0.0202	CcSEcCtD
Norepinephrine—Arbutamine—ADRB2—chronic obstructive pulmonary disease	0.000197	0.131	CrCbGaD
Norepinephrine—Sweating—Salbutamol—chronic obstructive pulmonary disease	0.000196	0.0184	CcSEcCtD
Norepinephrine—Salbutamol—ADRB2—chronic obstructive pulmonary disease	0.000191	0.127	CrCbGaD
Norepinephrine—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.000189	0.0177	CcSEcCtD
Norepinephrine—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.000181	0.017	CcSEcCtD
Norepinephrine—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.000179	0.0168	CcSEcCtD
Norepinephrine—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.000174	0.0163	CcSEcCtD
Norepinephrine—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.000174	0.0163	CcSEcCtD
Norepinephrine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000173	0.0162	CcSEcCtD
Norepinephrine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000171	0.016	CcSEcCtD
Norepinephrine—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.000164	0.0154	CcSEcCtD
Norepinephrine—Phenylephrine—CYP1A2—chronic obstructive pulmonary disease	0.000154	0.102	CrCbGaD
Norepinephrine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000146	0.0137	CcSEcCtD
Norepinephrine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000146	0.0137	CcSEcCtD
Norepinephrine—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000144	0.0135	CcSEcCtD
Norepinephrine—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000144	0.0135	CcSEcCtD
Norepinephrine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000144	0.0135	CcSEcCtD
Norepinephrine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000144	0.0135	CcSEcCtD
Norepinephrine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000141	0.0132	CcSEcCtD
Norepinephrine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000138	0.013	CcSEcCtD
Norepinephrine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000136	0.0128	CcSEcCtD
Norepinephrine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000136	0.0127	CcSEcCtD
Norepinephrine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000126	0.0118	CcSEcCtD
Norepinephrine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000123	0.0116	CcSEcCtD
Norepinephrine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000123	0.0116	CcSEcCtD
Norepinephrine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000117	0.0109	CcSEcCtD
Norepinephrine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000116	0.0108	CcSEcCtD
Norepinephrine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000114	0.0107	CcSEcCtD
Norepinephrine—Droxidopa—ADRB2—chronic obstructive pulmonary disease	0.000113	0.0753	CrCbGaD
Norepinephrine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000109	0.0102	CcSEcCtD
Norepinephrine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000107	0.0101	CcSEcCtD
Norepinephrine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000107	0.0101	CcSEcCtD
Norepinephrine—Isoprenaline—ADRB2—chronic obstructive pulmonary disease	0.000103	0.0684	CrCbGaD
Norepinephrine—Epinephrine—TNF—chronic obstructive pulmonary disease	9.76e-05	0.0649	CrCbGaD
Norepinephrine—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	9.43e-05	0.00883	CcSEcCtD
Norepinephrine—Isoprenaline—CYP1A1—chronic obstructive pulmonary disease	8.82e-05	0.0587	CrCbGaD
Norepinephrine—Vomiting—Formoterol—chronic obstructive pulmonary disease	8.8e-05	0.00825	CcSEcCtD
Norepinephrine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	8.8e-05	0.00825	CcSEcCtD
Norepinephrine—Headache—Arformoterol—chronic obstructive pulmonary disease	8.67e-05	0.00812	CcSEcCtD
Norepinephrine—Headache—Formoterol—chronic obstructive pulmonary disease	8.67e-05	0.00812	CcSEcCtD
Norepinephrine—Epinephrine—ADRB2—chronic obstructive pulmonary disease	8.65e-05	0.0575	CrCbGaD
Norepinephrine—Vomiting—Montelukast—chronic obstructive pulmonary disease	8.62e-05	0.00808	CcSEcCtD
Norepinephrine—Headache—Montelukast—chronic obstructive pulmonary disease	8.49e-05	0.00796	CcSEcCtD
Norepinephrine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	8.31e-05	0.00779	CcSEcCtD
Norepinephrine—Headache—Salbutamol—chronic obstructive pulmonary disease	8.19e-05	0.00767	CcSEcCtD
Norepinephrine—Dopamine—SLC6A4—chronic obstructive pulmonary disease	8.04e-05	0.0535	CrCbGaD
Norepinephrine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	7.93e-05	0.00743	CcSEcCtD
Norepinephrine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	7.81e-05	0.00731	CcSEcCtD
Norepinephrine—Dopamine—CYP1A2—chronic obstructive pulmonary disease	7.32e-05	0.0487	CrCbGaD
Norepinephrine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	7.25e-05	0.00679	CcSEcCtD
Norepinephrine—Epinephrine—CYP1A2—chronic obstructive pulmonary disease	7.15e-05	0.0475	CrCbGaD
Norepinephrine—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	6.85e-05	0.00642	CcSEcCtD
Norepinephrine—Hypertension—Prednisone—chronic obstructive pulmonary disease	5.76e-05	0.0054	CcSEcCtD
Norepinephrine—Anxiety—Prednisone—chronic obstructive pulmonary disease	5.66e-05	0.00531	CcSEcCtD
Norepinephrine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	5.27e-05	0.00493	CcSEcCtD
Norepinephrine—Headache—Prednisolone—chronic obstructive pulmonary disease	4.7e-05	0.0044	CcSEcCtD
Norepinephrine—Vomiting—Prednisone—chronic obstructive pulmonary disease	3.46e-05	0.00324	CcSEcCtD
Norepinephrine—Headache—Prednisone—chronic obstructive pulmonary disease	3.41e-05	0.0032	CcSEcCtD
Norepinephrine—ADRB3—connective tissue—chronic obstructive pulmonary disease	6.4e-06	0.131	CbGeAlD
Norepinephrine—DRD2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	4.33e-06	0.000188	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.33e-06	0.000188	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—NOS3—chronic obstructive pulmonary disease	4.27e-06	0.000185	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	4.27e-06	0.000185	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	4.24e-06	0.000184	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	4.24e-06	0.000184	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—KL—chronic obstructive pulmonary disease	4.21e-06	0.000183	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	4.17e-06	0.000181	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.15e-06	0.00018	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	4.13e-06	0.000179	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	4.09e-06	0.000177	CbGpPWpGaD
Norepinephrine—ADRA2B—Hemostasis—VEGFA—chronic obstructive pulmonary disease	4.06e-06	0.000176	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	4.04e-06	0.000175	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	4.03e-06	0.000175	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—CTGF—chronic obstructive pulmonary disease	3.98e-06	0.000173	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.93e-06	0.000171	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.89e-06	0.000168	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.88e-06	0.000168	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.87e-06	0.000168	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.84e-06	0.000166	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.82e-06	0.000166	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.82e-06	0.000166	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.8e-06	0.000165	CbGpPWpGaD
Norepinephrine—ADRA2C—Hemostasis—VEGFA—chronic obstructive pulmonary disease	3.79e-06	0.000164	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.79e-06	0.000164	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.77e-06	0.000163	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.76e-06	0.000163	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.75e-06	0.000163	CbGpPWpGaD
Norepinephrine—ADRA2B—Hemostasis—TGFB1—chronic obstructive pulmonary disease	3.73e-06	0.000162	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.71e-06	0.000161	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.67e-06	0.000159	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—ALB—chronic obstructive pulmonary disease	3.66e-06	0.000159	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.61e-06	0.000156	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.56e-06	0.000155	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.56e-06	0.000154	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.56e-06	0.000154	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.55e-06	0.000154	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.54e-06	0.000153	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.52e-06	0.000153	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.51e-06	0.000152	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.5e-06	0.000152	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—NOS3—chronic obstructive pulmonary disease	3.5e-06	0.000152	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.49e-06	0.000151	CbGpPWpGaD
Norepinephrine—ADRA2C—Hemostasis—TGFB1—chronic obstructive pulmonary disease	3.48e-06	0.000151	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.47e-06	0.000151	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.47e-06	0.00015	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.46e-06	0.00015	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.4e-06	0.000147	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.37e-06	0.000146	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.34e-06	0.000145	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.32e-06	0.000144	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.3e-06	0.000143	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.28e-06	0.000142	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.28e-06	0.000142	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.25e-06	0.000141	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.22e-06	0.00014	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.22e-06	0.00014	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.19e-06	0.000138	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.18e-06	0.000138	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.16e-06	0.000137	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.16e-06	0.000137	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.16e-06	0.000137	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.14e-06	0.000136	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.13e-06	0.000136	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.12e-06	0.000135	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.1e-06	0.000135	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.1e-06	0.000134	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.09e-06	0.000134	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—VEGFA—chronic obstructive pulmonary disease	3.08e-06	0.000134	CbGpPWpGaD
Norepinephrine—ADRA2B—Hemostasis—TP53—chronic obstructive pulmonary disease	3.07e-06	0.000133	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.06e-06	0.000133	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.04e-06	0.000132	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.02e-06	0.000131	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.97e-06	0.000129	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.95e-06	0.000128	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.93e-06	0.000127	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.9e-06	0.000126	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.89e-06	0.000125	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.88e-06	0.000125	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.88e-06	0.000125	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.88e-06	0.000125	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.88e-06	0.000125	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.87e-06	0.000124	CbGpPWpGaD
Norepinephrine—ADRA2C—Hemostasis—TP53—chronic obstructive pulmonary disease	2.86e-06	0.000124	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.86e-06	0.000124	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.85e-06	0.000124	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.83e-06	0.000123	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	2.83e-06	0.000123	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.82e-06	0.000122	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.81e-06	0.000122	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.81e-06	0.000122	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.77e-06	0.00012	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.74e-06	0.000119	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.74e-06	0.000119	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.71e-06	0.000117	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.68e-06	0.000116	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.68e-06	0.000116	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.67e-06	0.000116	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.66e-06	0.000115	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.66e-06	0.000115	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.66e-06	0.000115	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.64e-06	0.000114	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.62e-06	0.000114	CbGpPWpGaD
Norepinephrine—ADRB1—connective tissue—chronic obstructive pulmonary disease	2.62e-06	0.0536	CbGeAlD
Norepinephrine—ADRB3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.61e-06	0.000113	CbGpPWpGaD
Norepinephrine—SLC22A3—connective tissue—chronic obstructive pulmonary disease	2.6e-06	0.0532	CbGeAlD
Norepinephrine—ADRA1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.58e-06	0.000112	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.57e-06	0.000112	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.56e-06	0.000111	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.56e-06	0.000111	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.55e-06	0.000111	CbGpPWpGaD
Norepinephrine—SLC6A2—respiratory system—chronic obstructive pulmonary disease	2.53e-06	0.0518	CbGeAlD
Norepinephrine—ADRA1B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.52e-06	0.000109	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.52e-06	0.000109	CbGpPWpGaD
Norepinephrine—ADRB1—bronchus—chronic obstructive pulmonary disease	2.45e-06	0.0501	CbGeAlD
Norepinephrine—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.44e-06	0.000106	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.43e-06	0.000105	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.41e-06	0.000105	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	2.41e-06	0.000104	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.4e-06	0.000104	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.38e-06	0.000103	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.38e-06	0.000103	CbGpPWpGaD
Norepinephrine—SLC22A3—smooth muscle tissue—chronic obstructive pulmonary disease	2.38e-06	0.0487	CbGeAlD
Norepinephrine—ADRA1B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.34e-06	0.000102	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.34e-06	0.000102	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.34e-06	0.000101	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—TP53—chronic obstructive pulmonary disease	2.33e-06	0.000101	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.33e-06	0.000101	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.32e-06	0.000101	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.32e-06	0.000101	CbGpPWpGaD
Norepinephrine—DRD2—respiratory system—chronic obstructive pulmonary disease	2.3e-06	0.0472	CbGeAlD
Norepinephrine—SLC22A2—Metabolism—ALB—chronic obstructive pulmonary disease	2.29e-06	9.94e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.25e-06	9.74e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.24e-06	9.71e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—ALB—chronic obstructive pulmonary disease	2.23e-06	9.67e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.22e-06	9.61e-05	CbGpPWpGaD
Norepinephrine—SLC18A2—lung—chronic obstructive pulmonary disease	2.2e-06	0.0451	CbGeAlD
Norepinephrine—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	2.2e-06	9.53e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.19e-06	9.51e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.18e-06	9.43e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.16e-06	9.37e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.16e-06	9.37e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.15e-06	9.31e-05	CbGpPWpGaD
Norepinephrine—SLC22A5—respiratory system—chronic obstructive pulmonary disease	2.15e-06	0.044	CbGeAlD
Norepinephrine—SLC22A1—Metabolism—ALB—chronic obstructive pulmonary disease	2.14e-06	9.27e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—NOS3—chronic obstructive pulmonary disease	2.13e-06	9.25e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.12e-06	9.17e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.12e-06	9.17e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.11e-06	9.13e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.1e-06	9.09e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.08e-06	9.03e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.08e-06	9.02e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.07e-06	8.97e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.04e-06	8.86e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.02e-06	8.75e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2e-06	8.67e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.98e-06	8.56e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.96e-06	8.49e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—respiratory system—chronic obstructive pulmonary disease	1.94e-06	0.0398	CbGeAlD
Norepinephrine—ADRA2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.93e-06	8.39e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.93e-06	8.36e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.93e-06	8.35e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.91e-06	8.28e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.89e-06	8.17e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.88e-06	8.14e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.87e-06	8.1e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—bronchus—chronic obstructive pulmonary disease	1.84e-06	0.0378	CbGeAlD
Norepinephrine—ADRA1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.84e-06	7.97e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—ALB—chronic obstructive pulmonary disease	1.81e-06	7.85e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.78e-06	7.74e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.78e-06	7.73e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.78e-06	7.7e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.77e-06	7.66e-05	CbGpPWpGaD
Norepinephrine—SLC22A5—bronchus—chronic obstructive pulmonary disease	1.77e-06	0.0362	CbGeAlD
Norepinephrine—ADRA1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.76e-06	7.61e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—NOS3—chronic obstructive pulmonary disease	1.73e-06	7.51e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.71e-06	7.42e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.71e-06	7.41e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.7e-06	7.36e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.7e-06	7.35e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.69e-06	7.35e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.69e-06	7.32e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.67e-06	7.25e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.67e-06	7.22e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—trachea—chronic obstructive pulmonary disease	1.66e-06	0.0339	CbGeAlD
Norepinephrine—ADRA1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.63e-06	7.08e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.63e-06	7.05e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.62e-06	7.02e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.62e-06	7.02e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.61e-06	6.98e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.59e-06	6.9e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.59e-06	6.9e-05	CbGpPWpGaD
Norepinephrine—SLC22A5—trachea—chronic obstructive pulmonary disease	1.59e-06	0.0325	CbGeAlD
Norepinephrine—ADRA2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.58e-06	6.86e-05	CbGpPWpGaD
Norepinephrine—ADRB1—lung—chronic obstructive pulmonary disease	1.58e-06	0.0323	CbGeAlD
Norepinephrine—ADRA2A—connective tissue—chronic obstructive pulmonary disease	1.57e-06	0.0322	CbGeAlD
Norepinephrine—SLC22A3—lung—chronic obstructive pulmonary disease	1.57e-06	0.0321	CbGeAlD
Norepinephrine—ADRA1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.56e-06	6.76e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.56e-06	6.75e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.55e-06	6.73e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.55e-06	6.7e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.53e-06	6.64e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.52e-06	6.61e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.52e-06	6.58e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.51e-06	6.56e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.5e-06	6.52e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.48e-06	6.42e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.47e-06	6.38e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—bronchus—chronic obstructive pulmonary disease	1.47e-06	0.0301	CbGeAlD
Norepinephrine—ADRA2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.45e-06	6.28e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.44e-06	6.23e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.43e-06	6.21e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.41e-06	6.11e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.4e-06	6.06e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.39e-06	6.02e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.38e-06	6e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.38e-06	5.97e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.37e-06	5.95e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.37e-06	5.92e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.36e-06	5.89e-05	CbGpPWpGaD
Norepinephrine—SLC6A2—lung—chronic obstructive pulmonary disease	1.34e-06	0.0275	CbGeAlD
Norepinephrine—ADRA2A—trachea—chronic obstructive pulmonary disease	1.32e-06	0.0271	CbGeAlD
Norepinephrine—ADRA1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.32e-06	5.7e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.3e-06	5.63e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.29e-06	5.57e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.29e-06	5.57e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.27e-06	5.53e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.27e-06	5.48e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.26e-06	5.48e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.25e-06	5.43e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.25e-06	5.42e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.25e-06	5.41e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.24e-06	5.37e-05	CbGpPWpGaD
Norepinephrine—DRD2—lung—chronic obstructive pulmonary disease	1.22e-06	0.0251	CbGeAlD
Norepinephrine—ADRB2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.22e-06	5.3e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.22e-06	5.3e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—lung—chronic obstructive pulmonary disease	1.19e-06	0.0244	CbGeAlD
Norepinephrine—ADRA2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.18e-06	5.11e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.17e-06	5.06e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.16e-06	5.04e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.16e-06	5.03e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.16e-06	5.01e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.15e-06	4.99e-05	CbGpPWpGaD
Norepinephrine—SLC22A5—lung—chronic obstructive pulmonary disease	1.14e-06	0.0233	CbGeAlD
Norepinephrine—ADRA1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.14e-06	4.94e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.12e-06	4.87e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.07e-06	4.64e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.05e-06	4.57e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.05e-06	4.55e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.05e-06	4.55e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.04e-06	4.53e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.04e-06	4.51e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—lung—chronic obstructive pulmonary disease	1.03e-06	0.0211	CbGeAlD
Norepinephrine—ADRA1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.03e-06	4.47e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.03e-06	4.45e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.01e-06	4.38e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	1e-06	4.34e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	9.71e-07	4.21e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	9.6e-07	4.16e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.58e-07	4.15e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	9.57e-07	4.15e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	9.56e-07	4.14e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	9.52e-07	4.13e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—lung—chronic obstructive pulmonary disease	9.49e-07	0.0194	CbGeAlD
Norepinephrine—ADRB2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	9.4e-07	4.07e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	9.4e-07	4.07e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	8.89e-07	3.85e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	8.81e-07	3.82e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	8.75e-07	3.79e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	8.49e-07	3.68e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	8.07e-07	3.5e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.89e-07	3.42e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.77e-07	3.37e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.22e-07	3.13e-05	CbGpPWpGaD
